amounted to Baht 1,225.80 million, fell by Baht 21.73 million or 1.74% last year. Net interest- bearing debt registered Baht 27,844.03 Million at the end of 2019, an increase of Baht 82.43 Million from the
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
The SEC has been invited to become a member of ASEAN Taxonomy Board (ATB) and has been participating in the meetings as a member from July 2024 onwards. The ATB was established and endorsed at the
sale of convertible bonds at lower market price” means an offer for sale of newly issued convertible bonds of which the offered price combined with the exercise price is within the scope of an offering
may decline, currently standing at B563, in exchange for higher ARPH (average revenue per household) in the long run. Expanded strategic digital services for both enterprise and consumer With a complete
quarter which contracted at 12.1%, because of the government expenditure and public investment expanded, while private consumption, private investment, and export of goods declined at a slower pace compared
(“the Company”) and its Subsidiary (“the Group”) would like to clarify the change in operating result for the year ended 31 December 2018, which net profit has changed more than 20% from the last year as
previous year or representing 10.8%. In this regard, the cause of the change was as follows: 1. Sales revenue for the mobile phone distribution decreased in the third quarter of 2019 by 1,651.3 million Baht
following details. Financial performance Statement of income Consolidated financial statements for the year 2018 2017 Change (Audited) (Audited/Restated) Increase (Decrease) THB Million % THB Million % THB
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 021/2563 February 27, 2020 Subject: Clarification of the Operating Result for the significant change Attention